Latest News
FDA Modifies REMS Requirements for Sublingual Sufentanil
Sleep Restriction Decreases GABAergic Cortical Inhibition During Interictal Migraine Phase
Cannabis Use Linked to Increased Opioid Consumption After Lumbar Fusion
CDC: Be Alert for Rashes Consistent With Monkeypox
Neuromuscular Electrical Stimulation Therapy Improves Knee OA Symptoms
Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020
Wearable TENS Device Cleared for Fibromyalgia Treatment
Sleep Problems Not a Major Issue in Rheumatoid Arthritis
FDA Declines EUA Request for Fluvoxamine for COVID-19 Treatment
Are Biologic Therapies Effective for Neuropathic Pain?
FDA Authorizes Direct-to-Consumer, OTC Test to Detect COVID-19, Influenza, and RSV
Warning Letters Sent to Online Pharmacies Illegally Selling Schedule II Stimulants
Delays in Care Longer for Female Trauma Patients
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Latest Features
Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
COVID Fatigue: Is It Over Yet?
Jim Anderson, MPAS, PA-C, explores COVID-19 fatigue and how it is all a bit numbing for medical providers who are trying to do their best to treat patients while clinging to trusted sources to help guide the way.
HIPAA Potentially at Odds With New Laws on Gender-Affirming Care
States are enacting legislation that would require health care providers to violate patients’ privacy rights under HIPAA.
Gender Bias Common in Online Reviews of Physicians
Patients rated female doctors more on their interpersonal skills and not much on their technical competence, a study found.
Topical NSAIDs as First-Line Treatment for Osteoarthritis
Authors outline the efficacy and safety of topical NSAIDs for the treatment of acute and chronic musculoskeletal pain conditions including osteoarthritis.
- Loading...
Loading...
Loading... 
Loading...